Superbugs in the coming new decade;: multidrug resistance and prospects for treatment of Staphylococcus aureus, Enterococcus spp. and Pseudomonas aeruginosa in 2010

被引：158

作者：

Nordmann, Patrice ^{[1
]}

Naas, Thierry ^{[1
]}

Fortineau, Nicolas ^{[1
]}

Poirel, Laurent ^{[1
]}

机构：

[1] Univ Paris Sud, Hop Bicetre, Fac Med Paris Sud, F-94275 Le Kremlin Bicetre, France

来源：

CURRENT OPINION IN MICROBIOLOGY | 2007年 / 10卷 / 05期

关键词：

D O I：

10.1016/j.mib.2007.07.004

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

New resistance problems have emerged recently among hospital and community-acquired pathogens such as in Staphylococcus aureus, Enterococcus faecium and Pseudomonas aeruginosa. Hospital-acquired and now community-acquired methicillin-resistant S. aureus are emerging worldwide whereas vancomycin-resistant S. aureus remain extremely rare. Hospital-acquired outbreaks of vancomycin-resistant enterococci and multidrug resistant Pseudomonas aeruginosa infections are increasingly reported worldwide. Whereas novel molecules are being developed for treating Gram-positive infections, difficult to non possible-to-treat pandrug-resistant P. aeruginosa infections may become a therapeutic challenge soon.

引用

收藏

页码：436 / 440

页数：5

相关论文

共 45 条

[1] MRSA - the tip of the iceberg [J].

Appelbaum, PC .

CLINICAL MICROBIOLOGY AND INFECTION, 2006, 12 :3-10

[2] Functional and structural characterization of the genetic environment of an extended-spectrum β-lactamase blaVEB gene from a Pseudomonas aeruginosa isolate obtained in India [J].

Aubert, D ;

Girlich, D ;

Naas, T ;

Nagarajan, S ;

Nordmann, P .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (09) :3284-3290

[3] Controlling methicillin-resistant Staphylococcus aureus:: Quantifying the effects of interventions and rapid diagnostic testing [J].

Bootsma, MCJ ;

Diekmann, O ;

Bonten, MJM .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (14) :5620-5625

[4] Meticillin-resistant Staphylococcus aureus [J].

Boyce, JM ;

Cookson, B ;

Christiansen, K ;

Hori, S ;

Vuopio-Varkila, J ;

Kocagöz, S ;

Öztop, AY ;

Christiansen, K ;

Hori, S ;

Vuopio-Varkila, J ;

Kocagöz, S ;

Öztop, AY ;

Vandenbroucke-Grauls, CMJE ;

Harbarth, S ;

Pittet, D .

LANCET INFECTIOUS DISEASES, 2005, 5 (10) :653-663

[5] Anti-MRSA β-lactams in development, with a focus on ceftobiprole:: the first anti-MRSA β-lactam to demonstrate clinical efficacy [J].

Bush, Karen ;

Heep, Markus ;

Macielag, Mark J. ;

Noel, Gary J. .

EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2007, 16 (04) :419-429

[6] Vancomycin resistance in gram-positive cocci [J].

Courvalin, P .

CLINICAL INFECTIOUS DISEASES, 2006, 42 :S25-S34

[7] Look before you leap: Active surveillance for multidrug-resistant organisms [J].

Diekema, Daniel J. ;

Edmond, Michael B. .

CLINICAL INFECTIOUS DISEASES, 2007, 44 (08) :1101-1107

[8] Complete genome sequence of USA300, an epidemic clone of community-acquired meticillin-resistant Staphylococcus aureus [J].

Diep, BA ;

Gill, SR ;

Chang, RF ;

Phan, TH ;

Chen, JH ;

Davidson, MG ;

Lin, F ;

Lin, J ;

Carleton, HA ;

Mongodin, EF ;

Sensabaugh, GF ;

Perdreau-Remington, F .

LANCET, 2006, 367 (9512) :731-739

[9]

Docquier JD, 2001, EMERG INFECT DIS, V7, P910

[10] Coproduction of novel 16S rRNA methylase RmtD and metallo-β-lactamase SPM-1 in a panresistant Pseudomonas aeruginosa isolate from Brazil [J].

Doi, Yohei ;

de Oliveira Garcia, Doroti ;

Adams, Jennifer ;

Paterson, David L. .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2007, 51 (03) :852-856

← 1 2 3 4 5 →